Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases β-amyloid toxicity in cortical neurons
Open Access
- 9 January 2003
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 84 (2), 347-362
- https://doi.org/10.1046/j.1471-4159.2003.01526.x
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A decade of CDK5Nature Reviews Molecular Cell Biology, 2001
- A Cdk5–p35 Stable Complex Is Involved in the β-Amyloid-Induced Deregulation of Cdk5 Activity in Hippocampal NeuronsExperimental Cell Research, 2001
- Tau Phosphorylation at Serine 396 and Serine 404 by Human Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote Microtubule AssemblyPublished by Elsevier BV ,2000
- Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5Proceedings of the National Academy of Sciences, 2000
- Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal deathFEBS Letters, 1999
- Molecular effects of paclitaxel: Myths and reality (a critical review)International Journal of Cancer, 1999
- Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833British Journal of Cancer, 1997
- Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegenerationBiochemical Journal, 1997
- β-Amyloid fibrils induce tau phosphorylation and loss of microtubule bindingNeuron, 1995
- Shared Actions of Endotoxin and Taxol on TNF Receptors and TNF releaseScience, 1990